If you don’t know us, ask the firms that do.
They’ll tell you Axinn is a law firm that cuts through complexity to create advantage.
Welcome to Axinn
Experienced and trial-ready, we tackle complex legal challenges shaping clients' businesses worldwide. Our U.S. teams focus on antitrust, intellectual property, and high-stakes litigation across technology, healthcare, life sciences, and consumer sectors, delivering collaborative, client-first service that drives opportunity and results.
Our Practices
Professionals
Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
Deals & Cases
Deals & Cases
Axinn Secures Win for Google in Ad Tech Case
Deals & Cases
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Axinn Represents Tecomet in Closing of Merger with Orchid Orthopedic
Deals & Cases
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Represents Park Place Technologies, GTCR, and Charlesbank in Park Place’s Acquisition by Service Express
Deals & Cases
Antitrust
Axinn Advises Boyd Group Services on its Acquisition of Joe Hudson’s Collision Center
Deals & Cases
Antitrust
Axinn Advises Thermo Fisher Scientific in Strategic Acquisition of Clario Holdings Inc.
Deals & Cases
Antitrust
Axinn Advises Thermo Fisher Scientific on its Acquisition of the Purification & Filtration Business of Solventum
Deals & Cases
Antitrust
Axinn Advises AssuredPartners in its Acquisition by Arthur J. Gallagher & Co.
Deals & Cases
Featured Insights
Featured Insights
Antitrust Exemptions for Competitor Collaborations in the Spotlight: Recent Uses of the Defense Production Act
Axinn Viewpoints
Antitrust
Eight Axinn Partners Recognized in Lawdragon’s Seventh “500 Leading Dealmakers” Guide
Awards & Recognitions
Antitrust
Takeaways from the Consero Healthcare General Counsel Forum
Axinn Viewpoints
Antitrust
Parsing The Latest Signals On FTC Section 5 Enforcement
Byline Articles
Antitrust
Anti-Steering Provisions Remain In Antitrust Limelight As Class Action Lawsuits Proceed Through Court
Axinn Viewpoints
Antitrust
Henkel/Liquid Nails: The Evidence That Drove the Court’s Merger Decision
Axinn Viewpoints
Antitrust
Another HSR penalty record — KKR’s $250 million settlement
Byline Articles
Antitrust
What Companies Should Know About California’s COMPETE Act
Axinn Viewpoints
Antitrust
Survival vs. Antitrust: Inside the FTC’s Strict Standards for "Failing" Hospital Acquisitions
Axinn Viewpoints
Antitrust
Axinn Partners Named to Lawdragon’s 2027 "500 Leading Litigators in America” Guide
Awards & Recognitions
Antitrust











